Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2015 · 10-Q
Revenue$392.83K$392.83K+168,497.9% vs Q3 2014 Net Income-$56.89K-$56.89KN/M vs Q3 2014 EPS, diluted—
Operating Income$6,279N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$37,614N/M Margins · derivedGross margin71.2%+1001.2 pt vs Q3 2014
Operating margin1.6%+41260.4 pt vs Q3 2014
Net margin-14.5%+2849025.4 pt vs Q3 2014
ended Sep 30, 2015 · filed Nov 16, 2015 · 47 d after period end